160 Health International Ltd. (Ticker: 2656 HK) is a China-based pharmaceutical and healthcare product wholesaler and a leading digital healthcare integrated service provider operating the Healthcare 160 Platform. 160 Health plans to list on the HKEX on Sept. 17, 2025, offering 33.65 million common shares at HKD 14.86 per share, to raise approximately HKD 499.97 million (about USD 64.20 million). The company serves business customers and individual users with a wide assortment of pharmaceutical and healthcare products under wholesale and retail models, and provides online healthcare and wellness solutions connecting institutions, medical professionals and users across China. The syndicate includes ABCI Capital, BOCI Asia, Eddid Securities & Futures, Livermore Holdings, Shenwan Hongyuan Securities (HK), and South China Securities. A 15% greenshoe (5.05 million shares) is available.